Products Categories
CAS No.: | 3459-20-9 |
---|---|
Name: | glymidine sodium |
Molecular Structure: | |
Formula: | C13H15 N3 O4 S . Na |
Molecular Weight: | 331.35 |
Synonyms: | Benzenesulfonamide,N-[5-(2-methoxyethoxy)-2-pyrimidinyl]-, sodium salt (8CI,9CI); Sodium,[N-[5-(2-methoxyethoxy)-2-pyrimidinyl]benzenesulfonamido]- (7CI); BS 717;Glycanol; Glycodiazin; Glycodiazine; Glycodiazine sodium; Glyconormal;Glymidine; Glymidine sodium; Glymidine sodium salt; Gondafon; Lycanol;N-[5-(2-Methoxyethoxy)-2-pyrimidinyl]benzenesulfonamide sodium; Redul; RedulIF; Redul sodium; SH 717; Sodium2-benzenesulphonylamino-5-(2-methoxyethoxy)pyrimidine; Sodiumbenzenesulfonamide, N-[5-(2-methoxyethoxy)-2-pyrimidinyl]-; Sodiumglycodiazine; Sodium glymidine |
Density: | 1.354g/cm3 |
Melting Point: | 221-226° |
Boiling Point: | 515.1°Cat760mmHg |
Flash Point: | 265.4°C |
Safety: | Moderately toxic by ingestion, intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic fumes of SOx, NOx, and Na2O. |
PSA: | 90.00000 |
LogP: | 2.24220 |
1. | orl-rat LD50:2850 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 14 (1964),377. | ||
2. | ipr-rat LD50:3120 mg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),221. | ||
3. | scu-rat LD50:2800 mg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),221. | ||
4. | ivn-rat LD50:2000 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 14 (1964),377. | ||
5. | orl-mus LD50:5300 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 14 (1964),377. | ||
6. | ipr-mus LD50:3210 mg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),221. | ||
7. | scu-mus LD50:3340 mg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),221. | ||
8. | ivn-mus LD50:1480 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 14 (1964),377. |